Search details
1.
How I treat thrombocytopenia in pregnancy.
Blood
; 143(9): 747-756, 2024 Feb 29.
Article
in English
| MEDLINE | ID: mdl-37992219
2.
Rilzabrutinib, an Oral BTK Inhibitor, in Immune Thrombocytopenia.
N Engl J Med
; 386(15): 1421-1431, 2022 04 14.
Article
in English
| MEDLINE | ID: mdl-35417637
3.
Cognitive impairment among patients with chronic immune thrombocytopenia.
Br J Haematol
; 2024 May 09.
Article
in English
| MEDLINE | ID: mdl-38724473
4.
Efficacy and safety of the neonatal Fc receptor inhibitor efgartigimod in adults with primary immune thrombocytopenia (ADVANCE IV): a multicentre, randomised, placebo-controlled, phase 3 trial.
Lancet
; 402(10413): 1648-1659, 2023 11 04.
Article
in English
| MEDLINE | ID: mdl-37778358
5.
Sutimlimab in Cold Agglutinin Disease.
N Engl J Med
; 384(14): 1323-1334, 2021 04 08.
Article
in English
| MEDLINE | ID: mdl-33826820
6.
SARS-CoV-2 vaccination and ITP in patients with de novo or preexisting ITP.
Blood
; 139(10): 1564-1574, 2022 03 10.
Article
in English
| MEDLINE | ID: mdl-34587251
7.
Fostamatinib for warm antibody autoimmune hemolytic anemia: Phase 3, randomized, double-blind, placebo-controlled, global study (FORWARD).
Am J Hematol
; 99(1): 79-87, 2024 Jan.
Article
in English
| MEDLINE | ID: mdl-37929318
8.
The latest insights into rare blood disorders: Diagnosis and treatment strategies.
Am J Hematol
; 2024 Mar 09.
Article
in English
| MEDLINE | ID: mdl-38459819
9.
Avatrombopag for adults with early versus chronic immune thrombocytopenia.
Am J Hematol
; 99(2): 155-162, 2024 Feb.
Article
in English
| MEDLINE | ID: mdl-38063420
10.
New insights into the glycobiology of immune thrombocytopenia.
Curr Opin Hematol
; 30(6): 210-218, 2023 11 01.
Article
in English
| MEDLINE | ID: mdl-37526945
11.
Efficacy and safety of givosiran for acute hepatic porphyria: Final results of the randomized phase III ENVISION trial.
J Hepatol
; 79(5): 1150-1158, 2023 Nov.
Article
in English
| MEDLINE | ID: mdl-37479139
12.
How I treat primary ITP in adult patients who are unresponsive to or dependent on corticosteroid treatment.
Blood
; 137(20): 2736-2744, 2021 05 20.
Article
in English
| MEDLINE | ID: mdl-33827138
13.
Sustained inhibition of complement C1s with sutimlimab over 2 years in patients with cold agglutinin disease.
Am J Hematol
; 98(8): 1246-1253, 2023 08.
Article
in English
| MEDLINE | ID: mdl-37246953
14.
Novel therapies for immune thrombocytopenia.
Br J Haematol
; 196(6): 1311-1328, 2022 03.
Article
in English
| MEDLINE | ID: mdl-34611885
15.
COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection.
Blood
; 136(4): 489-500, 2020 07 23.
Article
in English
| MEDLINE | ID: mdl-32492712
16.
Treatment of chemotherapy-induced thrombocytopenia in patients with non-hematologic malignancies.
Haematologica
; 107(6): 1243-1263, 2022 06 01.
Article
in English
| MEDLINE | ID: mdl-35642485
17.
Sutimlimab improves quality of life in patients with cold agglutinin disease: results of patient-reported outcomes from the CARDINAL study.
Ann Hematol
; 101(10): 2169-2177, 2022 Oct.
Article
in English
| MEDLINE | ID: mdl-35999387
18.
Efficacy and safety of givosiran for acute hepatic porphyria: 24-month interim analysis of the randomized phase 3 ENVISION study.
Liver Int
; 42(1): 161-172, 2022 01.
Article
in English
| MEDLINE | ID: mdl-34717041
19.
Fostamatinib for the treatment of warm antibody autoimmune hemolytic anemia: Phase 2, multicenter, open-label study.
Am J Hematol
; 97(6): 691-699, 2022 06 01.
Article
in English
| MEDLINE | ID: mdl-35179251
20.
Biomarkers associated with coronary high-risk plaques.
J Thromb Thrombolysis
; 54(4): 647-659, 2022 Nov.
Article
in English
| MEDLINE | ID: mdl-36205839